Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 27;22(3):365.
doi: 10.3390/molecules22030365.

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance

Affiliations
Review

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance

Gurpreet Kaur Grewal et al. Molecules. .

Abstract

Epilepsy is a neurological disorder affecting around 1%-2% of population worldwide and its treatment includes use of antiepileptic drugs to control seizures. Failure to respond to antiepileptic drug therapy is a major clinical problem and over expression of ATP-binding cassette transporters is considered one of the major reasons for pharmacoresistance. In this review, we have summarized the regulation of ABC transporters in response to oxidative stress due to disease and antiepileptic drugs. Further, ketogenic diet and antioxidants were examined for their role in pharmacoresistance. The understanding of signalling pathways and mechanism involved may help in identifying potential therapeutic targets and improving drug response.

Keywords: ABC transporters; antiepileptic drugs; epilepsy; oxidative stress; pharmacoresistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Modulation of ABC efflux transporter at blood brain barrier (BBB) by oxidative stress: possible mechanism of pharmacoresistance in epilepsy. Epilepsy results when the balance between neuronal excitability and inhibition is tipped towards excitability (1); This imbalance increases production of brain ROS molecules, leading to oxidative stress (2); The elevated stress in turn aggravates the epileptic condition forming a vicious cycle (3); First line AEDs given as a treatment to patients with epilepsy also raises oxidative stress levels, which become undesirable for the patients (4); This oxidative stress through activation of various signaling molecules such as Nrf2, NF-KB, PPARα etc. (5) alters the basal transporter expression (6); The resulting consequence is increased efflux of AEDs from brain (7); which are substrate of these transporters resulting in pharmacoresistant phenotype (8). To address the problem of oxidative stress damage, antioxidants as an adjunct therapy along with AEDs and ketogenic diet seem promising as efficient neuroprotectants. However, their role in pharmacoresistance is still unclear.

Similar articles

Cited by

References

    1. Wright J., Pickard N., Whitfield A., Hakin N. A population-based study of the prevalence, clinical characteristics and effect of ethnicity in epilepsy. Seizure. 2000;9:309–313. doi: 10.1053/seiz.2000.0422. - DOI - PubMed
    1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000;342:314–319. doi: 10.1056/NEJM200002033420503. - DOI - PubMed
    1. Rogawski M.A., Johnson M.R. Intrinsic Severity as a Determinant of Antiepileptic Drug Refractoriness. Epilepsy Curr. 2008;8:127–130. doi: 10.1111/j.1535-7511.2008.00272.x. - DOI - PMC - PubMed
    1. Remy S., Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain. 2006;129:18–35. doi: 10.1093/brain/awh682. - DOI - PubMed
    1. Sisodiya S.M. Mechanisms of antiepileptic drug resistance. Curr. Opin. Neurol. 2003;16:197–201. doi: 10.1097/00019052-200304000-00013. - DOI - PubMed

MeSH terms